Rebecca J. Critchley-Thorne

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

15h-index1.0kcitations71works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(59), Gastric Cancer Management and Outcomes(38), Esophageal and GI Pathology(29), Eosinophilic Esophagitis(10), Gastrointestinal Tumor Research and Treatment(5)

Publications71 total

S702 Risk-Aligned Management Guided by the Tissue Systems Pathology Test Can Improve Health Outcomes in Barrett’s Esophagus and Reduce Healthcare-Associated Costs
The American Journal of Gastroenterology·2024· 1 cited
Abstract ID: 83The tissue systems pathology test guides risk-aligned management decisions in patients with non-dysplastic Barrett's esophagus
Foregut The Journal of the American Foregut Society·2024
Abstract ID: 81TissueCypher is the strongest independent predictor of progression in patients with Barrett’s esophagus
Foregut The Journal of the American Foregut Society·2024· 1 cited
The Tissue Systems Pathology Test Objectively Risk-Stratifies Patients With Barrett’s Esophagus
Journal of Clinical Gastroenterology·2024· 5 citedOpen Access
Su1266 THE TISSUE SYSTEMS PATHOLOGY TEST PREDICTS RISK OF MALIGNANT PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Gastroenterology·2024· 1 cited
Su1267 THE TISSUE SYSTEMS PATHOLOGY TEST PROVIDES CLINICALLY ACTIONABLE RISK-STRATIFICATION IN PATIENTS WITH BARRETT'S ESOPHAGUS: A MULTICENTER U.S. CLINICAL EXPERIENCE
Gastroenterology·2024
392 THE TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT FOR PATIENTS WITH BARRETT'S ESOPHAGUS
Gastroenterology·2024
Comments on “TSP-9: A Barrett’s Esophagus Biomarker Better Than Pathologists?”
Gastroenterology·2023Open Access
S599 The Tissue Systems Pathology Test Predicts Risk of Progression in Medicare-Eligible Patients with Barrett’s Esophagus
The American Journal of Gastroenterology·2023
S600 The Tissue Systems Pathology Test Objectively Risk-Stratifies Patients with Barrett’s Esophagus: A Multicenter US Clinical Experience Study
The American Journal of Gastroenterology·2023
A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB
Clinical and Translational Gastroenterology·2023· 7 citedOpen Access
Topic: Esophagus Neoplasia (Barrett’s, Cancer)Abstract ID: 61A Tissue Systems Pathology Test Enables Risk-Aligned Management of Patients With Non-Dysplastic Barrett’s Esophagus: Case Reports From a Gastrointestinal Surgery Center
Foregut The Journal of the American Foregut Society·2023
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia
Gastroenterology·2023· 15 citedOpen Access
303. THE TISSUE SYSTEMS PATHOLOGY-9 TEST PROVIDES CLINICALLY-IMPACTFUL RISK STRATIFICATION IN PATIENTS WITH BARRETT’S ESOPHAGUS: CLINICAL EXPERIENCE IN A MULTICENTER COHORT
Diseases of the Esophagus·2023Open Access
A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus
Clinical and Translational Gastroenterology·2023· 12 citedOpen Access
An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus
The American Journal of Gastroenterology·2023· 10 citedOpen Access
A TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT OF PATIENTS WITH NON-DYSPLASTIC BARRETT’S ESOPHAGUS: A CASE SERIES AT AN EXPERT FOREGUT SURGERY CENTER
Gastrointestinal Endoscopy·2023
A TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT OF PATIENTS WITH NON-DYSPLASTIC BARRETT’S ESOPHAGUS: A CASE SERIES AT AN EXPERT FOREGUT SURGERY CENTER
Gastrointestinal Endoscopy·2023
222 A TISSUE SYSTEMS PATHOLOGY TEST OUTPERFORMS STANDARD CLINICOPATHOLOGIC VARIABLES IN PREDICTING PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS.
Gastroenterology·2023
Tu1271 A TISSUE SYSTEMS PATHOLOGY TEST ENABLES STANDARDIZED, RISK-ALIGNED MANAGEMENT OF PATIENTS WITH BARRETT'S ESOPHAGUS
Gastroenterology·2023
page 1 of 4Next →

Frequent Co-authors

Jacques Bergman(19), Jon M. Davison(15), Lucas C. Duits(13), Yi Zhang(13), David L. Diehl(13), Roos E. Pouw(10), D. Lansing Taylor(9), Gary W. Falk(9), Emily A. Bossart(9), Nicola Frei(9), Amir M. Khoshiwal(9), Jeffrey W. Prichard(8), Kathleen Repa(8), Lia M. Reese(8), Jinhong Li(8), Tyler Foxwell(8), Christian Smolko(8), Blair A. Jobe(7), Nirag Jhala(7), Gregory G. Ginsberg(7)